Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 11, 2020
Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma - a case reportRolf D Issels, Lars H Lindner, Michael von Bergwelt-Baildon, et al.
JAMA Oncology|February 17, 2018
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical TrialRolf D Issels, Lars H Lindner, Jaap Verweij, et al.
The Lancet. Oncology|May 4, 2010
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre studyRolf D Issels, Lars H Lindner, Jaap Verweij, et al.
Langenbeck'S Archives of Surgery|July 10, 2023
Ten recommendations for sarcoma surgery: consensus of the surgical societies based on the German S3 guideline "Adult Soft Tissue Sarcomas"Jens Jakob, Dimosthenis Andreou, Jens Bedke, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2022
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-StudiengruppeSimone Hettmer, Corinne M Linardic, Anna Kelsey, et al.
Oncology Research and Treatment|April 22, 2021
Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa StudyMartin Eichler, Dimosthenis Andreou, Henriette Golcher, et al.
Cold Spring Harbor Perspectives in Medicine|November 5, 2014
Rhabdomyosarcoma: current challenges and their implications for developing therapiesSimone Hettmer, Zhizhong Li, Andrew N Billin, et al.
Annals of Surgical Oncology|May 15, 2025
Radiologic and Pathologic Response Evaluation After Neoadjuvant Chemotherapy for Primary Retroperitoneal Sarcoma: A Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) CollaborationStijn J C van der Burg, Marco Fiore, Piotr Rutkowski, et al.
Geburtshilfe Und Frauenheilkunde|December 5, 2022
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Journal of Hematology & Oncology|August 16, 2022
Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German RegistryJudith Penkert, Farina J Strüwe, Christina M Dutzmann, et al.
Pageof 21